About
NovAb is the developer of monoclonal antibodies (mAbs) designed to utilize variable lymphocyte receptors (VLRs) to develop therapeutic drugs and diagnostic and biomedical research reagents. The company develops leucine-rich repeat motifs that form a rigid binding site structure that is contained within a single polypeptide for immune receptors that are not immunoglobulin (Ig) and a new category of research reagents that recognize glycans, thereby enabling researchers and scientists to enhance biomedical research and therapeutic strategies.
Tucker